The Barchart Chart of the Day belongs to the oncology stock NovoCure(NVCR). I found the stock by using Barchart to sort today's Top Stocks to Ownlist first by the highest Weighted Alpha, then I used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Spotter signaled a buy on 7/13 the stock gained 8.40%.
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.
Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.
Barchart technical indicators:
- 100% technical buy signals
- 129.90+ Weighted Alpha
- 100.88% gain in the last year
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 4 new highs and up 10.12% in the last month
- Relative Strength Index 71.26%
- Technical support level at 38.13
- Recently traded at 39.99 with a 50 day moving average of 34.50
Fundamental factors:
- Market Cap $3.60 billion
- Revenue expected to grow 42.00% this year and another 50.00% next year
- Earnings estimated to increase 5.70% this year, an additional 124.20% next year and continue to compound at an annual rate of 60.00% for the next 5 years
- Wall Street analysts issued 2 strong buy, 3 buy and 1 hold recommendation on the stock
